Asset management company Athyrium Capital Management said today that it and investment management company Neuberger Berman have closed a $2 billion healthcare fund seeking to invest in commercial-stage healthcare companies. The Athyrium Opportunities Fund III has more than 45 institutional investors including public and private pension funds, endowments, foundations and sovereign wealth funds, New York-based […]
SynCardia said it brought in another $14 million funding round, led by a $10 million contribution from SWK Holdings, that it plans to use to develop a smaller version of its total artificial heart.
Tucson-based SynCardia said Athyrium Capital Management contributed the remaining $4 million as a follow-on to its $10 million investment in March.
Syncardia put together a $19 million financing package to back the spinout of its total artificial heart technology, hard on the heels of an FDA win for the device.
The bulk of the financing, $15 million, was doled out by New York-based funding group Athyrium Investors, with the balance coming from existing backers.